TEHMINA USMANI: Open Payments
NPI 1164597563 · CERRITOS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$540 in 7 payments from 4 companies in 2025. Trend: 2023 $741 · 2024 $424 · 2025 $540
Food & beverage: $540
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 4 | $304 |
| E.R. Squibb & Sons, L.L.C. | 1 | $115 |
| Teva Pharmaceuticals USA, Inc. | 1 | $91 |
| Luye Pharma (USA) Ltd. | 1 | $29 |
Products named: INVEGA SUSTENNA, COBENFY, UZEDY, ERZOFRI EXTENDED-RELEASE.
Industry payments across CA — which companies pay providers there.
